Figure 1 1: Urological Device Market Share Ranking by Segment, China, 2019 3
Figure 1 2: Companies Researched in this Report, China 4
Figure 1 3: Factors Impacting the Urological Device Market by Segment, China 5
Figure 1 4: Recent Events in the Urological Device Market, 2017 – 2019 6
Figure 1 5: Urological Procedures Covered, China 7
Figure 1 6: Urological Device Markets Covered, China (1 of 2) 8
Figure 1 7: Urological Device Markets Covered, China (2 of 2) 9
Figure 1 8: Version History 9
Figure 3 1: Urinary Incontinence Treatments by Company (1 of 3) 53
Figure 3 2: Urinary Incontinence Treatments by Company (2 of 3) 54
Figure 3 3: Urinary Incontinence Treatments by Company (3 of 3) 55
Figure 3 4: Stone Management Devices by Company (1 of 3) 62
Figure 3 5: Stone Management Devices by Company (2 of 3) 63
Figure 3 6: Stone Management Devices by Company (3 of 3) 64
Figure 3 7: BPH Treatments by Company 73
Figure 3 8: Erectile Dysfunction Devices by Company 76
Figure 3 9: Class 2 Device Recall Auriga Laser System 77
Figure 3 10: Class 2 Device Recall Fiber Strippers and Cleavers 78
Figure 3 11: Class 2 Device Recall StarMedTec LightTrail Reusable Fibers 79
Figure 3 12: Class 2 Device Recall Malecot Catheter Set 79
Figure 3 13: Class 2 Device Recall Encore(TM) 26 Inflation Device 79
Figure 3 14: Class 2 Device Recall Bardex Lubricath 3Way 75cc Continuous Irrigation Foley Catheter 80
Figure 3 15: Class 2 Device Recall Intermittent Catheters 80
Figure 3 16: Class 2 Device Recall leg bag 80
Figure 3 17: Class 2 Device Recall SURESTEP 81
Figure 3 18: Class 2 Device Recall PureWick External Catheter 81
Figure 3 19: Class 2 Device Recall SURESTEP Tray, BARDEX I.C. COMPLETE CARE, Urine Meter, Temperature STATLOCK Stabilization Device 81
Figure 3 20: Class 2 Device Recall BARD Irrigation Syringe, Rx Only, Sterile 82
Figure 3 21: Class 2 Device Recall Magic3 82
Figure 3 22: Class 2 Device Recall Optionvm Urinary Catheter. Male use only. Latex Free. Sterile, Rx only. 82
Figure 3 23: Class 3 Device Recall SureStep Tray, with AddaFoley 83
Figure 3 24: Class 2 Device Recall BARDEX 83
Figure 3 25: Class 3 Device Recall BARD Toomey Irrigation Syringe 70cc 83
Figure 3 26: Class 3 Device Recall Antibacterial Hydro Personal Catheter 83
Figure 3 27: Class 2 Device Recall Magic3 Intermittent Catheter with Sure Grip Hydrophilic Coated Silicone Coude tip 84
Figure 3 28: Class 2 Device Recall Magic3 Hydrophiliccoated Female Intermittent Catheter 84
Figure 3 29: Class 2 Device Recall Bard 100 LatexFree Urinary Drainage Bag with AntiReflux Chamber and Bard EXLok Sampling 84
Figure 3 30: Class 2 Device Recall Bard Dimension Stone Basket 85
Figure 3 31: Class 2 Device Recall CMax 85
Figure 3 32: Class 2 Device Recall Bard BrachySource Seed Implants 85
Figure 3 33: Class 2 Device Recall I125 CE Marked QuickLink Cartridges 86
Figure 3 34: Class 2 Device Recall Bard 86
Figure 3 35: Class 2 Device Recall XForce Nephrostomy Balloon Dilation Catheter Kit with Inflation Device 87
Figure 3 36: Class 2 Device Recall SelfCath Pediatric Catheter 88
Figure 3 37: Class 2 Device Recall Coloplast Conveen Urine Collection Leg Bag 88
Figure 3 38: Class 2 Device Recall Genesis Malleable Penile Prosthesis 88
Figure 3 39: Class 2 Device Recall StoneBreaker 89
Figure 3 40: Class 2 Device Recall OptiLite MultiUse Holmium Laser Fibers 89
Figure 3 41: Class 2 Device Recall Cook MultiUse Holmium Laser Fibers 90
Figure 3 42: Class 2 Device Recall Cook Bush 90
Figure 3 43: Class 2 Device Recall Aprima" Access Nonvascular Introducer Set 90
Figure 3 44: Class 2 Device Recall Ascend AQ 91
Figure 3 45: Class 2 Device Recall Oncentra Brachy 4.5 92
Figure 3 46: Class 2 Device Recall Oncentra External Beam Treatment Planning Software 92
Figure 3 47: Class 2 Device Recall Oncentra External Beam Treatment Planning Software 92
Figure 3 48: Class 2 Device Recall Oncentra Brachy treatment planning system 92
Figure 3 49: Class 2 Device Recall STORZ High Flow Insufflation Tubing (with filter) 93
Figure 3 50: Class 2 Device Recall Image1 SPIES XLINK Camera Control Unit (CCU) 93
Figure 3 51: Class 2 Device Recall Ureteroreno Videoscope & Fiberscope 94
Figure 3 52: Class 2 Device Recall A20975A: Working insert, with ramp, one way; A20976A: Bridge, one way; A20977A; Bridge, two way 94
Figure 3 53: Class 2 Device Recall Olympus High Frequency Resection Electrodes 94
Figure 3 54: Class 2 Device Recall Ureteroreno videoscope URFV2 and URFV2R 95
Figure 3 55: Class 2 Device Recall HF Cable WA00014A 95
Figure 3 56: Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence (Solyx) 96
Figure 3 57: Mid-Urethral Sling Tensioning Trial (MUST) 96
Figure 3 58: Prospective Registry for Patients Undergoing Surgery for Male Stress Urinary Incontinence 97
Figure 3 59: Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP) (SOAP) 97
Figure 3 60: LithoVue Single Use Disposable Ureteroscope 98
Figure 3 61: Comparing Treatment of Urolithiasis Between Disposable and Reusable Ureteroscope 98
Figure 3 62: Indwelling Stent Discoloration Project 99
Figure 3 63: Reduction of Stent Associated Morbidity by Minimizing Stent Material. 99
Figure 3 64: PROPPER Prospective Registry of Outcomes With Penile Prosthesis (PROPPER) 100
Figure 3 65: Patient Satisfaction During Outpatient Versus Inpatient Foley Catheter Induction of Labor 101
Figure 3 66: Foley Catheter vs a Self-contained Valved Urinary Catheter 101
Figure 3 67: Bladder Morphology Using 2 Different Catheter Designs 102
Figure 3 68: Outpatient Labor Induction With the Transcervical Foley Balloon 102
Figure 3 69: Medical and Economic Evaluation for Intermediate-risk Prostate Cancer (GETUGP05) 103
Figure 3 70: Detection of Clinically Significant Prostate Cancer Using Transperineal Targeted Biopsy Compared to Standard Transrectal Biopsy 103
Figure 3 71: Product Evaluation of a Newly Developed Intermittent Catheter. 104
Figure 3 72: Clinical Study Investigating Safety and Performance of a New Urinary Intermittent Catheter in Healthy Volunteers 104
Figure 3 73: Clinical Study Investigating Safety and Performance of a New Urinary Intermittent Catheters in Healthy Volunteers 104
Figure 3 74: Virtue® European Study 105
Figure 3 75: Exploratory Study Investigating Urodynamic Parameters During Catheterisation 105
Figure 3 76: Altis® 522 Trial - Treatment of Female Stress Urinary Incontinence 105
Figure 3 77: The European Study of Altis Single Incision Sling System for Female Stress Urinary Incontinence (EASY) 106
Figure 3 78: Do Hydrophilic Catheters Decrease Pain and Discomfort of a Patient During Urodynamic Study (HYDRUDS) 106
Figure 3 79: Efficacy Study of Antimicrobial Catheters to Avoid Urinary Infections in Spinal Cord Injured Patients (ESCALE) 106
Figure 3 80: Ureteral Stent Study 107
Figure 3 81: Impact Ureteral Sheath Design During Ureteroscopy 107
Figure 3 82: Optimization of Ureterolysis During Hysterectomy 108
Figure 3 83: Suctioning Flexible Ureteroscopy With Intelligent Control of Renal Pelvic Pressure 108
Figure 3 84: Evaluation Of Transperineal Ultrasound For Image Guidance In The Treatment Of Prostate Cancer in Men Following Prostatectomy 109
Figure 3 85: Use of Non-invasive 4D Ultrasound Clarity System in Prostate IMRT/RapidArc Therapy 109
Figure 3 86: Single Fraction Real-time High-Dose-Rate Brachytherapy in Patients With Low and Intermediate Risk Prostate Cancer (SINFRA_PROST) 110
Figure 3 87: Dose Escalation to Dominant Intraprostatic Lesions (DIL) With MRI-TRUS Fusion High Dose Rate (HDR) Prostate Brachytherapy (BRAPROST) 110
Figure 3 88: Combined Treatment for Mixed Incontinence (ESTEEM) 111
Figure 3 89: TVT-ABBREVO Versus SERASIS for the Treatment of Female Urinary Stress Incontinence: 1 Year Outcomes of a Comparative Study With 2 Trans-obturator Sub Mid Urethral Slings 111
Figure 3 90: Trans-obturator Mid-urethral Sling and the Single-incision Sling in Women With Stress Urinary Incontinence 112
Figure 3 91: Low-energy Extracorporeal Shockwave Treatment for Patients After Radical Prostatectomy 113
Figure 3 92: Low-Intensity Extracorporeal Shockwave Therapy and Vacuum Erectile Device as a Treatment for Peyronies Disease 113
Figure 3 93: Safety and Effect of Low-Energy Extracorporeal Shockwave Therapy (ESWT) on the Renal Allograft in Transplant Recipients. 114
Figure 3 94: Low Energy Shockwave Therapy (LE-SWT): A Novel Treatment for Chronic Kidney Disease 114
Figure 3 95: Narrow Versus Wide Focal Zones for Shock Wave Lithotripsy of Renal Calculi 114
Figure 3 96: Are the Stone Density and Location Useful Parameters for Small Kidney Stones? 115
Figure 3 97: Durability of Flexible Ureteroscopes and Causes of Infection During Flexible Ureterorenoscopy 115
Figure 3 98: Comparison of Different Energy Sources During TUR-P 115
Figure 3 99: Effects of Flexible Ureteroscopy on Renal Blood Flow 116
Figure 3 100: A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting 116
Figure 3 101: Blue Light Cystoscopy With Cysview® Registry (BLCCR) 116
Figure 3 102: Safety Study of Bipolar Versus Monopolar Transurethral Resection of Bladder Tumors 117
Figure 3 103: Multi-Center Comparison of Dual Lumen Versus Single Lumen Ureteroscopes 117
Figure 3 104: T-DOC® 5 Fr Pediatric Clinical Investigation 118
Figure 3 105: Air vs Water Catheters (AvW (Bonn)) 118
Figure 3 106: A Human Factor Study To Asses The Usability And Feasibility Of The Peritron+ During Intended Use 119
Figure 3 107: Portable Pves Study 119
Figure 3 108: Ambulatory Pessary Trial 119
Figure 3 109: Study to Compare CAUTI Rates Following ERASE CAUTI Tray Non-Silver vs Silver Coated Foley Catheters 120
Figure 3 110: Study to Compare CAUTI Rates Following ERASE CAUTI Tray Silver vs Silver Coated Foley Catheters 120
Figure 3 111: Trial Comparing Three Different Devices for Kidney Stone Removal During Percutaneous Surgery 121
Figure 3 112: Quality of Life in Kidney Stone Patients Undergoing Surgery 121
Figure 3 113: Prostate Vaporization Techniques in Canadian Hospital 122
Figure 3 114: Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization Electrode 122
Figure 3 115: Assessment of Infection Control, Practice Efficiency, and Health Economics of Sheathed Versus Standard Cystoscopy 123
Figure 3 116: Results of Safety Guidewire Use in Ureteroscopic Stone Surgery 123
Figure 3 117: Transurethral En Bloc Versus Standard Resection of Bladder Tumour 123
Figure 3 118: PlasmaKinetic (PK) Button Vaporization Electrode for Treatment of Bladder Tumors (PK Button) 124
Figure 4 1: Currency Exchange Rate, 2019 127
Figure 4 2: Urological Device Market by Segment, China, 2016 – 2026 (US$M) 129
Figure 4 3: Urological Device Market by Segment, China, 2016 – 2026 (CN¥M) 130
Figure 4 4: Urological Device Market Growth by Segment, 2016 – 2026 135
Figure 4 5: Drivers and Limiters, Urological Device Market, China, 2019 142
Figure 4 6: Leading Competitors, Urological Device Market, China, 2019 150
Figure 4 7: SWOT Analysis, Boston Scientific, 2018 (1 of 2) 166
Figure 4 8: SWOT Analysis, Boston Scientific, 2018 (2 of 2) 167
Figure 4 9: SWOT Analysis, C. R. Bard (Becton Dickinson), 2018 (1 of 2) 168
Figure 4 10: SWOT Analysis, C. R. Bard (Becton Dickinson), 2018 (2 of 2) 169
Figure 4 11: SWOT Analysis, Coloplast, 2018 170
Figure 4 12: SWOT Analysis, Cook Medical, 2018 (1 of 2) 171
Figure 4 13: SWOT Analysis, Cook Medical, 2018 (2 of 2) 172
Figure 4 14: SWOT Analysis, Ethicon, 2018 173
Figure 4 15: SWOT Analysis, Karl Storz, 2018 174
Figure 4 16: SWOT Analysis, Laborie, 2018 175
Figure 4 17: SWOT Analysis, Olympus, 2018 (1 of 2) 176
Figure 4 18: SWOT Analysis, Olympus, 2018 (2 of 2) 177
Figure 5 1: Urological Procedures by Type, China, 2016 – 2026 179
Figure 5 2: Urinary Incontinence Procedures by Type, China, 2016 – 2026 183
Figure 5 3: Male Incontinence Management Procedures by Type, China, 2016 – 2026 185
Figure 5 4: Female Incontinence Management Procedures by Type, China, 2016 – 2026 188
Figure 5 5: Pelvic Organ Prolapse Repair Procedures by Type, China, 2016 – 2026 190
Figure 5 6: Stone Management Procedures by Type, China, 2016 – 2026 192
Figure 5 7: ESWL Procedures, China, 2016 – 2026 194
Figure 5 8: Transurethral Procedures by Type, China, 2016 – 2026 196
Figure 5 9: Ureteral Stent Placement Procedures, China, 2016 – 2026 198
Figure 5 10: PCNL Procedures, China, 2016 – 2026 200
Figure 5 11: BPH Procedures by Type, China, 2016 – 2026 202
Figure 5 12: Erectile Dysfunction Management Procedures by Type, China, 2016 – 2026 204
Figure 6 1: Urinary Incontinence Device Market by Segment, China, 2016 – 2026 (US$M) 208
Figure 6 2: Urinary Incontinence Device Market by Segment, China, 2016 – 2026 (CN¥M) 208
Figure 6 3: Urinary Catheter Market by Segment, China, 2016 – 2026 (US$M) 213
Figure 6 4: Urinary Catheter Market by Segment, China, 2016 – 2026 (CN¥M) 213
Figure 6 5: Intermittent Catheter Market, China, 2016 – 2026 215
Figure 6 6: Foley Catheter Market, China, 2016 – 2026 217
Figure 6 7: Male External Catheter Market, China, 2016 – 2026 219
Figure 6 8: Incontinence Management Device Market by Segment, China, 2016 – 2026 (US$M) 222
Figure 6 9: Incontinence Management Device Market by Segment, China, 2016 – 2026 (CN¥M) 222
Figure 6 10: Female Incontinence Sling Market by Type, China, 2016 – 2026 (US$M) 225
Figure 6 11: Female Incontinence Sling Market by Type, China, 2016 – 2026 (CN¥M) 225
Figure 6 12: Total Female Incontinence Sling Market, China, 2016 – 2026 227
Figure 6 13: Transvaginal Tape Female Incontinence Sling Market, China, 2016 – 2026 229
Figure 6 14: Transobturator Female Incontinence Sling Market, China, 2016 – 2026 231
Figure 6 15: Single-Incision Female Incontinence Sling Market, China, 2016 – 2026 233
Figure 6 16: Male Implantable Incontinence Device Market by Segment, U.S., 2016 – 2026 (US$M) 236
Figure 6 17: Male Implantable Incontinence Device Market by Segment, U.S., 2016 – 2026 (CN¥M) 236
Figure 6 18: Total Male Implantable Incontinence Device Market, China, 2016 – 2026 238
Figure 6 19: Male Incontinence Sling Market, China, 2016 – 2026 240
Figure 6 20: Male Artificial Urinary Sphincter Market, China, 2016 – 2026 242
Figure 6 21: Drivers and Limiters, Urinary Incontinence Device Market, China, 2019 246
Figure 6 22: Leading Competitors, Urinary Incontinence Device Market, China, 2019 250
Figure 7 1: Pelvic Organ Prolapse Repair Device Market by Segment, China, 2016 – 2026 (US$M) 255
Figure 7 2: Pelvic Organ Prolapse Repair Device Market by Segment, China, 2016 – 2026 (CN¥M) 255
Figure 7 3: Total Pelvic Organ Prolapse Repair Device Market, China, 2016 – 2026 260
Figure 7 4: Transvaginal Mesh Market, China, 2016 – 2026 263
Figure 7 5: Sacrocolpopexy Mesh Market, China, 2016 – 2026 265
Figure 7 6: Drivers and Limiters, Pelvic Organ Prolapse Repair Device Market, China, 2019 268
Figure 7 7: Leading Competitors, Pelvic Organ Prolapse Repair Market, China, 2019 270
Figure 8 1: Stone Management Device Market by Segment, China, 2016 – 2026 (US$M) 275
Figure 8 2: Stone Management Device Market by Segment, China, 2016 – 2026 (CN¥M) 276
Figure 8 3: ESWL Equipment Market, China, 2016 – 2026 281
Figure 8 4: ISWL Equipment Market, U.S., 2016 – 2026 283
Figure 8 5: Holmium Laser Market by Segment, China, 2016 – 2026 (US$M) 285
Figure 8 6: Holmium Laser Market by Segment, China, 2016 – 2026 (CN¥M) 286
Figure 8 7: Holmium Laser Equipment Market, China, 2016 – 2026 288
Figure 8 8: Holmium Laser Fiber Market, China, 2016 – 2026 291
Figure 8 9: Stone Fragment Retrieval Device Market by Segment, China, 2016 – 2026 (US$M) 293
Figure 8 10: Stone Fragment Retrieval Device Market by Segment, China, 2016 – 2026 (CN¥M) 294
Figure 8 11: Total Stone Fragment Retrieval Device Market, China, 2016 – 2026 296
Figure 8 12: Nitinol Stone Fragment Retrieval Device Market, China, 2016 – 2026 298
Figure 8 13: Stainless Steel Stone Fragment Retrieval Device Market, China, 2016 – 2026 300
Figure 8 14: Ureteral Stent Market, China, 2016 – 2026 303
Figure 8 15: Ureteral Guidewire Market, China, 2016 – 2026 305
Figure 8 16: Drivers and Limiters, Stone Management Device Market, China, 2019 309
Figure 8 17: Leading Competitors, Stone Management Device Market, China, 2019 315
Figure 9 1: BPH Treatment Device Market by Segment, U.S., 2016 – 2026 (US$M) 321
Figure 9 2: BPH Treatment Device Market by Segment, U.S., 2016 – 2026 (CN¥M) 321
Figure 9 3: TURP Market by Segment, China, 2016 – 2026 (US$M) 326
Figure 9 4: TURP Market by Segment, China, 2016 – 2026 (CN¥M) 326
Figure 9 5: Monopolar Electrode Market, China, 2016 – 2026 328
Figure 9 6: Bipolar Electrode Market, U.S., 2016 – 2026 330
Figure 9 7: Laser BPH Market by Segment, China, 2016 – 2026 (US$M) 333
Figure 9 8: Laser BPH Market by Segment, China, 2016 – 2026 (CN¥M) 333
Figure 9 9: Laser BPH Equipment Market, China, 2016 – 2026 335
Figure 9 10: Laser BPH Fiber Market, China, 2016 – 2026 337
Figure 9 11: Drivers and Limiters, BPH Treatment Device Market, China, 2019 344
Figure 9 12: Leading Competitors, BPH Treatment Device Market, China, 2019 348
Figure 10 1: Erectile Dysfunction Device Market by Segment, China, 2016 – 2026 (US$M) 352
Figure 10 2: Erectile Dysfunction Device Market by Segment, China, 2016 – 2026 (CN¥M) 353
Figure 10 3: Inflatable Erectile Dysfunction Device Market, China, 2016 – 2026 358
Figure 10 4: Malleable Erectile Dysfunction Device Market, China, 2016 – 2026 360
Figure 10 5: Drivers and Limiters, Erectile Dysfunction Device Market, China, 2019 364
Figure 10 6: Leading Competitors, Erectile Dysfunction Device Market, China, 2019 366
